FAQ/Help |
Calendar |
Search |
Today's Posts |
01-03-2023, 11:07 AM | #1 | |||
|
||||
Senior Member
|
This announcement from the MS Association of America (December 28, 2022) gives details about the latest FDA-approved MS drug, Briumvi (ublituximab):
FDA Approves Briumvi™ for the Treatment of Relapsing Forms of MS | MSAA
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
ALS drug receives FDA approval | ALS News & Research | |||
UK to speed up drug approval ... | Parkinson's Disease | |||
FDA To Strengthen Generic Drug Program...Streamline Generic Drug Approval Process | Parkinson's Disease |